Transcript Joint Program Executive Office for Chemical and Biological Defense JOINT PROGRAM EXECUTIVE OFFICE Overview of POM FY06 Funding April 26, 2005 Advanced Planning Brief.

Joint Program Executive Office for Chemical and Biological Defense
JOINT PROGRAM EXECUTIVE OFFICE
Overview of POM FY06 Funding
April 26, 2005
Advanced Planning Brief to Industry
CHARLES H. CUTSHALL
Chief Financial Officer
Joint Program Executive Office
for Chemical and Biological Defense
703.681.9610
[email protected]
050425_APBI_JPEO
1
Joint Program Executive Office for Chemical and Biological Defense
Transforming Acquisition Support Systems
Defense
Acquisition
System
Milestone Decision
Authority Oversight
Planning,
Programming,
Budgeting
and Execution
Process
Joint Capabilities
Integration and
Development
System
DEPSECDEF
Oversight
Joint Chiefs of Staff
Oversight
050425_APBI_JPEO
2
Joint Program Executive Office for Chemical and Biological Defense
POM Build
• Integrated Validated UFRs, Tech Base Efforts and
Test & Evaluation Requirements with Advanced
Development Program Events and Milestones
• Used the 1-4-2-1 Requirements Construct and Gaps
Identified by the Baseline Capabilities Assessment to
Realign CBDP Resources
• Final Draft CBDP POM was Forwarded to the
Executive Agent (Army) and OSD for Review/
Approval by the JRO Where it Was Rejected by the
Services
• Additional IPE/ Reconnaissance Procurement was
Added and Accepted by the Services. ATSD NCB
Signed Final POM on August 2, 2004
050425_APBI_JPEO
3
Joint Program Executive Office for Chemical and Biological Defense
S&T, T&E – Advanced Development
Alignment
Advanced Development &
FY04
Procurement
FY05
FY06
FY07
FY08
FY09
FY10
FY11
TRE Tentage
Inc 1
MS C
Inc 2
Inc 3
Inc 2
MS C
MS B
Structure
MS B
MS C
MS B
Inc 3
MS B
Test & Evaluation (T&E)
Integrate and Establish Validated Test
Methods and Documentation
Overarching Model for Hazard
Assessment
Advanced Technologies Tests
Standardized Sim Tests for Platforms
NTA Testing
Science & Technology (S&T)
Adaptive Seals
MS C
MS C
Funded By
JSTO
TFOC
TIOC
JSTO
JSTO
JSTO
JSTO
Transition
RLIs, Enhanced Aerosol/Particle Removal, Reg
Filtration, Self Detox Mats, Adv Airlocks,
Expedient Coatings
Transition
NTAs, Adaptive Seals, Adv Airlocks
Transition
050425_APBI_JPEO
4
Joint Program Executive Office for Chemical and Biological Defense
Enhanced Planning Process (EPP)
• EPP was Formalized and Implemented by PBD 753
– CBRN Infrastructure Improvements at USAMRIID Received
$813.0M in MILCON Funding (HA)
– JSTO Technology Base Funding was Augmented by $587.0M
• Non-Medical - $209.5M (35.7%)
• Medical - $174.9M (29.8%)
• Modeling and Simulation - $172.6M (29.4%)
• Emerging Threats/ Special Projects - $30.0M (5.1%)
– Test & Evaluation was Provided $442.0M
• $100.0M in RDT&E BA3 Provided for Test Technology Transition
• MRTFB Sustainment was Provided $161.0M in RDT&E BA6
Funding to Facilitate Current Operations
• BA7 Funding was Augmented by $48.0M to Provide Upgrades and
Modernization to T&E Instrumentation and Infrastructure
• Advanced Development Test Capability was Given $135.0M
050425_APBI_JPEO
5
Joint Program Executive Office for Chemical and Biological Defense
Enhanced Planning Process (EPP)
• The JPEO had $336.0 Added for BA4/ 5 Efforts
– $ 72.5M in BA4/ 5 to Joint Expeditionary Collective Protection
– New Start
– $ 51.5M in BA4 RDT&E Funding was Added to Facilitate
Radiological Protectants – New Start
– Funded $ 43.5M in RDT&E BA4 for VEE Vaccine
– $ 38.0M in BA4/ 5 RDT&E Funding for the Joint Biological
Tactical Detection System (JBTDS)
– $ 32.0M to the Improved Nerve Agent Treatment System
(INATS)
– $ 29.0M in BA5 Funding was Provided to JPM-IS (JEM and
JWARN)
050425_APBI_JPEO
6
Joint Program Executive Office for Chemical and Biological Defense
CBDP FY06-11 EPP Adds
($’s in M)
900
800
700
600
500
400
300
200
100
0
6.1
6.2
6.3 6.4 6.5
6.6
Total – $1,963,000,000
050425_APBI_JPEO
6.7 MILCON
7
Joint Program Executive Office for Chemical and Biological Defense
CBDP FY06-11 EPP Adds
($’s in M)
APPN
AMOUNT
PERCENT
RDT&E 6.1
$ 16.0
0.8%
RDT&E 6.2
$ 365.0
18.6%
RDT&E 6.3
$ 206.0
10.5%
RDT&E 6.4
$ 174.0
8.9%
RDT&E 6.5
$ 180.0
9.2%
RDT&E 6.6
$ 161.0
8.2%
RDT&E 6.7
$ 48.0
2.4%
Procurement
$
0.0
0.0%
MILCON
$ 813.0
41.4%
Total = $1,963,000,000
050425_APBI_JPEO
8
Joint Program Executive Office for Chemical and Biological Defense
PBD 746
• $100.0M in RDT&E, DW Added to the CBRN Defense
Programs in FY06 by the OSD Comptroller
– Techbase - Medical Biological BA1 - $28.0M
– Techbase - Medical Biological BA2 - $18.0M
– Techbase - Medical Biological BA3 - $28.0M
– Techbase - Technology Transition BA3 - $ 2.0M
– Ricin Vaccine - $5.6M in BA4 Funding
– Venezuelan Equine Encephalitis Vaccine - $7.0M in BA4 and
$5.0M in BA5 Funding
– Critical Reagents Program (CRP) - $6.4M in BA5 Funding
050425_APBI_JPEO
9
Joint Program Executive Office for Chemical and Biological Defense
CBDP FY06-11 POM
($’s in M)
5000
1400
4500
1200
4000
3500
1000
3000
800
2500
600
2000
1500
400
1000
200
500
0
0
6.1 6.2 6.3 6.4 6.5 6.6 6.7 MILCON
Proc
Total – $9,917,665,000
050425_APBI_JPEO
10
Joint Program Executive Office for Chemical and Biological Defense
Revised CBD FY06-11 Program
($’s in M)
APPN
AMOUNT
PERCENT
RDT&E 6.1
$ 346.0
3.5%
RDT&E 6.2
$ 1,026.9
10.3%
RDT&E 6.3
$ 941.0
9.5%
RDT&E 6.4
$ 442.4
4.5%
RDT&E 6.5
$ 1,302.0
13.1%
RDT&E 6.6
$
4660
4.7%
RDT&E 6.7
$
88.6
0.9%
Procurement
$ 4,491.1
45.3%
MILCON (HA)
$ 813.0
8.2%
Total = $9,917,665,000
050425_APBI_JPEO
11
Joint Program Executive Office for Chemical and Biological Defense
CBD FY06-11 Program Totals
($’s in M)
5000
1400
4500
EPP
1200
4000
3500
1000
3000
800
2500
600
2000
1500
400
1000
200
500
0
6.1
6.2 6.3 6.4
6.5 6.6
6.7
Proc
0
Total – $9,104,665,000
050425_APBI_JPEO
12
Joint Program Executive Office for Chemical and Biological Defense
Congressional Adds
After You Have Succeeded in Obtaining Appropriated
Funding Remember To…
– Prepare and Forward a Project Description that can be Used
as the Basis for a Statement of Work (SOW)
• Break Up the Effort into Component Pieces
• Identify Schedule for the Completion of Phases/ Efforts
• Specify Deliverables to the Government
– Explain Why Your Product, Process or Technology is
Effective, Unique and Different
• Critical Capability
• Urgent and Compelling Need
• Only One Competent Provider
050425_APBI_JPEO
13
Joint Program Executive Office for Chemical and Biological Defense
Congressional Adds
Why Does it Take So Long For Us to Get Our Money?
– Normal Funds Release is 6 - 10 Weeks After the Beginning of
the Fiscal Year
– Congressionals Are Not Typically Released With Program-ofrecord Funding
– Members Do Not Provide a Direct Link to the Add so the
Actual Beneficiary is Unknown
– SOWs and Sole Source Justifications Often Require Multiple
Rewrites
– Workload Prioritization Issues at the JPEO and in the
Contracting Office
– It’s a Bureaucratic Process With Lots of Hoops to Jump
Through
050425_APBI_JPEO
14
Joint Program Executive Office for Chemical and Biological Defense
The Bottom Line – Return on Investment
050425_APBI_JPEO
15